Search results
Tematy dnia
10 lip 2024 · Twice-yearly injections of Lenacapavir showed overwhelming efficacy for preventing HIV infections compared to standard oral preventative HIV medicines, known as pre-exposure prophylaxis (PrEP). Additional trials are ongoing in Argentina, Brazil, Mexico, Peru, South Africa, Thailand and the United States.
28 lis 2023 · Young people, aged 15–24, account for around 27% of new HIV infections globally. Yet in eastern and southern Africa — the region of the world most severely affected by HIV — only 25% of ...
Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology. Working like scissors, but at the molecular level, it cuts...
26 wrz 2024 · WHO welcomes the latest findings from the PURPOSE-2 trial on long-acting injectable lenacapavir (LEN) for HIV prevention. An interim analysis, announced on 12 September 2024, demonstrated the drug’s remarkable efficacy in preventing HIV.
25 lip 2024 · During the 25th International AIDS Conference (AIDS 2024), being held in Munich, Germany, a new case of long HIV remission was reported and fuels optimism for an eventual HIV cure.
2 wrz 2024 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
26 mar 2024 · Researchers a step closer to a cure for HIV. A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. By 2030, the World...
